More than half of pharmaceuticals in the United States have a dependency on manufacturers not compliant to the Trade Agreements Act, which the Department of Defense defines as high- and very high-risk medications.
Twenty-seven percent of NDCs are sourced from high risk areas, or non-TAA compliant suppliers, and 27% are from very high-risk sources, or complete dependence on manufacturers in China and unknown countries.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,